Company Profiles

driven by the PitchBook Platform

Accelalox

Accelalox
2005 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$229K LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a biotechnology and pharmaceutical company. The company develops therapies to treat muscle and bone conditions focusing on oral and small-molecule therapy.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
325 Sharon Park Drive
Suite 310
Menlo Park, CA 94025
United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Accelalox’s full profile, request a free trial.

Accelalox Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 05-Aug-2010 $229K 00000 Completed Generating Revenue
1. Convertible Debt 30-Sep-2009 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Accelalox Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0

Accelalox Executive Team (2)

Name Title Board
Seat
Contact
Info
Julia O'Connor Co-Founder & Chief Executive Officer
J. Patrick O'Connor Ph.D Co-Founder, Board Member, Chairman of Scientific Advisory Board & Chief Scientific Officer
Questions or concerns about this profile? Reach out to website-support@pitchbook.com